• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Live UK pricing:

Nuformix PLC (NFX)

ORD 0.05P
Sell: 0.10p|Buy: 0.12p|Change: 0.01 (-4.35%)

Open 

0.115p

Previous close 

0.115p

Trade high 

0.11p

Volume 

28,166,414

Year high 

0.555p

Year low 

0.10p

Dividend yield 

–

Market capitalisation 

£2.87 mn

P/E ratio 

–

ISIN 

GB00BYW79Y38

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment

Share price

Performance 16/10/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

Total return (%)
Nuformix PLC- 4.35
More...

Company profile

Nuformix PLC is a pharmaceutical development company. It operates in pharmaceutical development, targeting unmet medical needs in fibrosis and oncology through drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.

Sector 

Healthcare

News

Recent trades

DateTimePriceQuantityValue (£)
16/10/202604:14:180.11100,000110.00
16/10/202603:45:100.1033290,417300.00
16/10/202602:37:050.15230.52
16/10/202602:36:260.112,000,0002,200.00
16/10/202602:29:590.11100,000110.00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.